SYK Stryker Earnings and EPS analysis

Relative Growth: Rel. Growth: 72

Relative Strength: Rel. Strength: 35

Relative Valuation: Rel. Valuation: 19

Relative Profitability: Rel. Profitability: 69

EPS in 2025 (TTM): $7.72

Last Report Period Date: Sep 30, 2025

As of November this year, based on Stryker's most recent financial report, the company's trailing twelve months EPS is $7.72. During 2024, SYK reported a per-share earnings of $7.86, which shows a decline compared to the EPS of $8.34 recorded in 2023. Stryker's EPS for the quarterly period ending on Sep 30, 2025 came in at $2.25.

SYK earnings history

Historical annual and quarterly earnings per share (EPS) data for Stryker

EPS (TTM)

$7.72

EPS Growth YoY (Quarterly)

3.2%

EPS (Quarterly)

$2.25

EPS Growth (Quarterly)

-3%

The yearly earnings per share during 2024 was $7.86, a decline of 5.8% compared to $8.34 recorded in 2023. Over the quarter ending Sep 30, 2025, the earnings per share came in at $2.25, reflecting a 3.2% increase compared to the same quarter a year earlier. As of September 2025, the TTM EPS is $7.72. During 2023, the annual earnings per share was $8.34, representing an increase of 33.9% compared to 2022.

SYK EPS growth

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

3.2%

EPS growth YoY

-5.8%

EPS growth 3Y avg

14.1%

EPS growth 5Y avg

7.1%

Stryker has recorded a growth in earnings per share of 3.2% in the past 12 months (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 14.1% per year. Stryker had an average annual EPS growth of 7.1% in the last five years. When assessed over a ten-year period, SYK's average EPS annual growth was 19.2%.

SYK Earnings Waterfall

Breakdown of revenue, profit and net income for Stryker

SYK Earnings vs Peers

What are the earnings of SYK compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
EW Edwards Lifesciences Corp	11.85	202.2%	42.5%	33%
CNMD CONMED Corp	12.48	104.3%	26.1%	33.5%
JNJ Johnson & Johnson	17.83	-57.9%	-9.7%	0.4%
GMED Globus Medical Inc	23.39	-30.3%	-19.9%	-13.5%
MDT Medtronic plc	24.84	31%	-1.1%	0.3%
WAT Waters Corp	34.09	-1.1%	-1.5%	4.2%
SYK Stryker Corp	46.33	-5.8%	14.1%	7.1%
BSX Boston Scientific Corp	52.33	16.7%	22.2%	-17.9%
BAX Baxter International Inc	N/A	-124.2%	N/A	N/A
IART Integra Lifesciences Holdings Corp	N/A	-110.6%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.